The 2nd BioQual Conference on Full-Cycle Quality Innovation and Compliance of Biopharmaceuticals will be held in Suzhou on May 28-29, 2026.

With the core theme of "New Quality Paradigm: From Compliance Baseline to Excellence Leadership", this conference focuses on the most cutting-edge topics of concern in the biopharmaceutical industry. It will feature multiple thematic forums including Stem Cell Quality Control, ADC Process and Quality Control Frontiers, In vivo CAR-T Quality Control, CMC and Quality Control of Bispecific and Multispecific Antibodies, Cell Therapy Process and Quality Control, and CGT Regulatory Policies and Global Cooperation.

The event will bring together experts from regulatory authorities, leading academic researchers, pharmaceutical R&D directors, and CRO industry elites to conduct in-depth discussions on the challenges and solutions for full-process quality control of biopharmaceuticals from R&D to market launch.

Ms. Pang Lin, Director of the Cell Seed Department at Beijing Joinn Drug Testing Research Co., Ltd., has been invited to attend the conference and deliver an authoritative keynote speech entitled "Establishment and Quality Control of Stem Cell Testing Laboratories".

Meanwhile, Joinn Laboratories will also set up a booth (Booth #D06) at the conference. We warmly welcome industry colleagues to visit, exchange ideas and discuss cooperation opportunities.